U.S. Pharma Stock News

FTAI Aviation (FTAI) announced a strong third-quarter performance, with revenue and net income both increasing compared to last year’s results. The company also raised its quarterly dividend, reinforcing management’s positive outlook for shareholders. See our latest analysis for FTAI Aviation. Despite some choppiness in recent weeks, FTAI Aviation’s momentum is still impressive. A 19% share price gain over the past 90 days and 12% year-to-date show investors are rewarding the company’s robust...

The Clorox Company recently reported first quarter fiscal 2026 results, revealing US$1.43 billion in sales and US$80 million in net income, both lower than the previous year, while confirming a continued full-year guidance that anticipates further sales and earnings declines. The implementation of a new US ERP system led to temporary disruptions and market share losses, but Clorox expects these operational investments to support future productivity and long-term growth initiatives. We'll...

Heritage Insurance Holdings (HRTG) just announced its third quarter earnings, showing a sharp jump in both net income and earnings per share compared to last year, even though revenue growth was only modest. See our latest analysis for Heritage Insurance Holdings. Investors have clearly taken notice of Heritage Insurance Holdings’ remarkable turn in profitability, as the share price has soared 127.91% year-to-date and delivered a 140.09% total return over the past twelve months. Momentum has...

Okta (OKTA) shares have been drifting lower recently, with the stock slipping about 1% in the past day and down 6% for the month. Investors are closely watching valuation and growth dynamics after the company's latest performance. See our latest analysis for Okta. Zooming out, Okta’s share price has notched an 8.9% gain year-to-date. Some momentum earlier in 2024 is now fading as recent losses weigh on sentiment. However, its 11.3% total shareholder return over the past year still points to...

Wondering if Alvotech is undervalued or if there's a rare opportunity hiding in the recent stock swings? You're not alone. Let's dig into the numbers to see what the market might be missing. Alvotech's share price has been under pressure lately, dropping 35.5% in the last week and declining 61.6% year-to-date. This hints at a dramatic shift in market sentiment. Much of the recent movement can be traced to headlines around regulatory developments and ongoing biosimilar approvals, which have...

In the past week, Trane Technologies reported strong third quarter earnings, set new guidance for full-year 2025, and introduced a pioneering thermal management solution for gigawatt-scale AI data centers developed for the NVIDIA Omniverse DSX Blueprint. The company's recent innovations address the growing complexity and energy demands of AI data centers, strengthening its relevance in a rapidly expanding sector. We'll now explore how the recent AI data center product announcement may...

Wondering if Easterly Government Properties is a hidden bargain or just a value trap? We are about to break down what really matters when weighing up this stock's price. The share price has not painted a rosy picture recently, slipping by 0.3% in the last week and down a significant 25.2% so far this year. Recent news has put the company in the spotlight as market sentiment shifts around government-backed REITs. Developments tied to federal property leasing and broader commercial real estate...

Recent updates show J.M. Smucker Co facing a decline in financial strength, growth, and profitability rankings, with risks highlighted by low interest coverage and Altman Z-Score metrics that may signal future financial distress. This has raised industry concerns about the company’s ability to maintain performance levels seen in the past and to compete with peers. To understand the impact of softening financial metrics, we'll explore how this development shapes the company’s overall...

Chefs' Warehouse (CHEF) delivered strong third-quarter results, outpacing expectations with notable sales and income growth. The company also raised its full-year guidance, attracting attention from investors and industry watchers alike. See our latest analysis for Chefs' Warehouse. Chefs' Warehouse’s upbeat Q3 results and raised guidance have given the stock fresh momentum. The company has delivered a 14% share price return over the past month and a robust 48% total return for shareholders...

Earlier this month, AT&T entered into new credit agreements totaling US$29.5 billion and expanded its global IoT capability by launching an eSIM solution with Thales, which enables seamless and remote activation for connected devices across industries. This combination of sizable debt financing and advanced IoT offerings highlights AT&T’s dual focus on financial flexibility and technology-driven growth opportunities. We'll explore how AT&T's enhanced financial flexibility from this new debt...

PACS Group (PACS) announced that it has secured an extension of its forbearance agreements with lenders, giving the company more time to address financial and regulatory hurdles. This move is closely connected to its efforts to regain NYSE compliance. See our latest analysis for PACS Group. PACS Group’s string of regulatory challenges and the recent forbearance extension come as the company’s share price continues to reflect uncertainty, with a 1-year total shareholder return of -37.07%...

SelectQuote, Inc. ( NYSE:SLQT ) shareholders might be concerned after seeing the share price drop 18% in the last week...

Fortrea Holdings (FTRE) shared its third quarter earnings, showing an uptick in revenue and a narrower net loss compared to last year. The company also raised its full-year 2025 revenue guidance, signaling greater confidence in upcoming performance. See our latest analysis for Fortrea Holdings. After Fortrea Holdings announced improved third-quarter results and a raised revenue outlook, the market responded with a 67.5% share price gain over the past 90 days. Still, its year-to-date share...

Liquidia (LQDA) caught the market’s attention after reporting third-quarter earnings that showed a major revenue jump and its first profitable quarter since launching YUTREPIA, its therapy for pulmonary hypertension. See our latest analysis for Liquidia. After a blockbuster quarter, Liquidia’s share price has soared, boasting a 25% gain in the past three months and a stunning year-to-date return of over 110%. Total shareholder return has been even more impressive, reaching 136% in the past...

StoneX Group (SNEX) has seen its stock hold steady recently, with only modest changes over the past week and month. Investors may be considering its longer-term performance and consistent profitability as they evaluate the next move. See our latest analysis for StoneX Group. StoneX Group’s share price is still up nearly 29% for the year to date despite a recent pullback, and the 1-year total shareholder return sits at an impressive 33%. While momentum has cooled after delivering a remarkable...

Granite Construction (GVA) has seen its stock ease off by around 6% over the past month, even though revenue has remained steady and the company has reported significant growth in annual net income. The company’s longer-term returns remain in positive territory. See our latest analysis for Granite Construction. After a strong run earlier in the year, Granite Construction’s share price has eased back recently, but momentum over the longer term remains impressive. The stock’s 1-year total...

Alliance Resource Partners (ARLP) shares have seen some modest movement lately, gaining just over 1% in the past week but dipping slightly over the past month. Investors might be eyeing recent performance for clues about where the stock could head next. See our latest analysis for Alliance Resource Partners. While Alliance Resource Partners’ recent share price has seen only minor shifts, its broader run tells a more compelling story. Despite a dip so far this year, its one-year total...

Structure Therapeutics (GPCR) released its third-quarter earnings on Wednesday, revealing a much wider net loss compared to the previous year. The financial update put the company’s recent performance under greater scrutiny for investors. See our latest analysis for Structure Therapeutics. Despite widening losses, Structure Therapeutics has caught investors’ attention, with the stock surging more than 105% over the past 90 days. This momentum far outpaces its 1-year total shareholder return...

N-able (NABL) shares are making headlines after the company released its third-quarter results, which beat expectations and sparked renewed interest. Investors are eyeing the raised annual recurring revenue outlook as well as the roll-out of fresh cybersecurity solutions. See our latest analysis for N-able. Following the upbeat earnings and guidance update, N-able’s share price charged 9.4% higher in the past week, recouping some ground after a tough year that saw its 12-month total...

Nova Ltd. reported record third-quarter results with revenue of US$224.61 million and net income of US$61.42 million, alongside management issuing elevated fourth-quarter revenue guidance of US$215 million to US$225 million and diluted GAAP EPS of US$1.77 to US$1.95. The company highlighted exceptionally strong sales in advanced logic and memory segments, driving both its highest-ever quarterly sales and surpassing analysts’ expectations for the upcoming quarter. We'll explore how Nova's...

PotlatchDeltic (PCH) shares have edged up over the past day, reflecting a modest 2.5% gain. This follows a stretch where the stock has drifted slightly lower over the month; however, it remains positive year-to-date. See our latest analysis for PotlatchDeltic. PotlatchDeltic’s share price has perked up after some recent softness, but overall momentum has cooled. A 3.45% year-to-date share price return and a five-year total shareholder return of 27.2% highlight the company’s mixed journey...

BeOne Medicines (NasdaqGS:ONC) reported its third quarter earnings, surprising investors with a return to profitability and a sizable revenue jump. The results surpassed expectations and the company also provided an upward revision to full-year revenue guidance. See our latest analysis for BeOne Medicines. Momentum is clearly building behind BeOne Medicines. The 1-day share price return of 3.41%, a 7.83% gain over the last week, and an 80.63% share price return year-to-date all reflect...

Curious if Occidental Petroleum is actually a bargain right now? You are not alone, as plenty of investors are wondering if the current price reflects the true value of the business. After a 19.7% slide over the past year and down 19.1% so far this year, the stock's moves have turned heads, especially following a five-year gain of 276.1% that still looms large in investor memories. Recently, Occidental has drawn attention due to news surrounding its significant carbon capture investments and...

Zimmer Biomet Holdings (ZBH) stock has seen gradual shifts lately, prompting investors to review recent performance and underlying trends. The company’s share price has slid over the past month and past 3 months, reflecting broader pressures across the medical device sector. See our latest analysis for Zimmer Biomet Holdings. Zooming out, Zimmer Biomet Holdings’ momentum has clearly faded over the past year. Share price returns have slipped, and the total shareholder return was -18% for the...